Introduction {#S0001}
============

Globally, it has been estimated that approximately 2.1 million adolescents aged 10--19 years are living with HIV, with nearly 85% of this population residing in sub-Saharan Africa (SSA) \[[1](#CIT0001)\]. Whilst initiatives to improve access to antiretroviral therapy (ART) in low- and middle-income countries (LMIC) contributed to a 30% decline in AIDS-related mortality between 2005 and 2012 \[[2](#CIT0002)\], adolescents have been left behind. In the same time-period, AIDS-related mortality amongst adolescents increased by 50%, with over 90% of these deaths occurring in SSA \[[1](#CIT0001)\].

The clustering of adolescent AIDS-related mortality in SSA is largely attributable to an approximate 10-year time-lapse in ART interventions compared to high-income nations \[[3](#CIT0003)\]. Many of the children perinatally infected in SSA, while prevention of mother-to-child transmission (PMTCT) programme coverage was still low, are now reaching their adolescence \[[4](#CIT0004),[5](#CIT0005)\]. However, less than 30% of adolescent girls and 10% of adolescent boys aged 15--19 years in SSA report ever having undergone an HIV test \[[6](#CIT0006)\]. In addition, the regional adolescent population has been projected to double by 2050, with adolescents making up approximately 46% of the total population \[[6](#CIT0006)\].

Recent global initiatives have called for adolescent health to be prioritized as young people represent a "triple dividend" investment -- of benefit now, to the next generation of adults and to the health of generations to come \[[7](#CIT0007)\]. At the heart of these initiatives lies the need to prevent and treat infections among this population, making care and treatment for ALHIV a policy priority for many African governments. This places new pressures on health systems and services to meet the needs of a rapidly expanding generation of both diagnosed and undiagnosed adolescents living with HIV (ALHIV) \[[5](#CIT0005),[8](#CIT0008)\].

Transition from childhood into adulthood is characterized by rapid physical, mental and sexual development, and in addition to this, ALHIV have complex emotional, psychological and health-related requirements that need to be reconciled to effectively manage their lives with HIV \[[4](#CIT0004)\]. In SSA, the majority of ALHIV under 14 years of age have been infected perinatally \[[9](#CIT0009)\] and many are orphaned by one or both parents \[[10](#CIT0010)\] forcing them into early emotional maturity and adult responsibilities. Furthermore, while some have been on ART since a very young age, others have been living with the virus untreated for over a decade. Without access to ART, those untreated are not expected to survive beyond their teenage years \[[9](#CIT0009)\]. For those that do survive, great efforts are needed to increase care access and improve retention on ART to reduce AIDS-related mortality and onward horizontal transmission of HIV \[[9](#CIT0009)\].

Quantitative research indicates that in many settings ALHIV experience higher rates of loss to follow-up and virological failure than both adults and children living with HIV \[[11](#CIT0011)--[14](#CIT0014)\]. Geographically discreet qualitative studies in different countries in SSA suggest that stigma, challenges in disclosure and consent policies for testing and treatment are reasons for faltering ALHIV care engagement, however, there has been no published synthesis of these studies. Meta-ethnographic methods enable an in-depth assessment of various health-related research topics \[[15](#CIT0015),[16](#CIT0016)\], including factors that influence patient care experiences and medication adherence in LMIC \[[17](#CIT0017),[18](#CIT0018)\]. Meta-ethnography aims to expand upon, or develop new interpretations of qualitative data. The "constant comparison" approach is used to determine if themes across varying contexts are reciprocal (complementary concepts) or refutational (contradictory concepts), supporting further hypothesis development \[[17](#CIT0017),[19](#CIT0019)--[21](#CIT0021)\]. Our meta-ethnography includes qualitative studies undertaken across the region, in order to understand the most influential issues affecting adolescent initiation of, and retention in, HIV care in SSA. Our synthesis of 10 years of qualitative research conducted since the advent of ART expansion enables a longitudinal line of inquiry, allowing us to assess changes across time, in different countries in SSA and across all stages of the HIV care cascade.

Theoretical frameworks {#S0001-S2001}
----------------------

The HIV care cascade describes progression through HIV diagnosis, care and treatment services and is commonly defined in five stages: (i) HIV diagnosis, (ii) linkage to care, (iii) engagement/retention in care, (iv) ART initiation and (v) viral suppression \[[22](#CIT0022), [23](#CIT0023)\]. The cascade has been widely used as a framework to explore reasons for patient attrition between these five stages, with some variations in the definitions for each stage depending on the study design or nature of the data that are available. For example, in relation to stage v, qualitative studies often explore patients' experiences of adherence to antiretroviral therapy, rather than investigating viral suppression per se, which is more commonly measured in studies with a quantitative design \[[24](#CIT0024),[25](#CIT0025)\].

For adolescents, traversing the cascade is complicated by the lack of autonomy in care-seeking that characterizes this age-group, including the requirement for guardian accompaniment to access services. Further disruptions in HIV care among adolescents have been noted to occur during the transition from paediatric into adult care \[[26](#CIT0026)\] or as they transition in and out of PMTCT programmes \[[27](#CIT0027),[28](#CIT0028)\]. Such challenges perpetuate the risk of attrition and associated mortality \[[26](#CIT0026),[29](#CIT0029)\]. "Engagement" with the HIV care cascade involves the willingness and ability of ALHIV to undergo HIV testing, initiate treatment, adhere to ART and negotiate the linkages between different HIV services and models of care (e.g. paediatric and adult; pre-ART and ART). This engagement with HIV care and treatment is influenced by a multitude of factors including basic service access, economic capability, and awareness of their HIV status \[[30](#CIT0030)\].

The socio-ecological model (SEM) has been frequently used across HIV literature to illustrate the range of social influences on health behaviours, including care fallout \[[31](#CIT0031),[32](#CIT0032)\]. The SEM is particularly useful in exploring health decisions made by individuals in LMIC or communities with high levels of disease stigmatization \[[33](#CIT0033)--[35](#CIT0035)\]. The model illustrates four levels of influence on health decisions ([Figure 1](#F0001)): i) s*tructural* factors, such as health systems, policies and underlying poverty; ii) *community* factors, including social norms around treatment-seeking and beliefs surrounding disease aetiology; iii) *family and peer* influences, including expectations of behaviours within these social contexts; iv) and *individual* factors at the model's core, including knowledge, perceptions, self-efficacy and risks associated with care-seeking. Influential factors may act across more than one level of the SEM: for example, family influences on adolescents' care-seeking behaviours may be affected by structural factors such as economic circumstances of the household or consent policies that limit access to services.Figure 1.The four levels of the socio-ecological model that have the potential to affect health behaviours, with examples of factors that operate at each level.

Methods {#S0002}
=======

Search strategy {#S0002-S2001}
---------------

For each search, five essential concepts were identified: HIV, adolescents, SSA, barriers /facilitators and each of the five stages of the care cascade. All possible search terms and synonyms for each concept were established and multiple spellings were incorporated. We searched five databases known for having a high volume of social and health-related research or articles specific to adolescents: PubMed, Web of Science, Scopus, Global Health and ADOLEC. Titles and abstracts of identified literature were imported into EndNote and reviewed to eliminate duplicates. References from highly relevant articles and systematic reviews were further checked for additional eligible articles.

Inclusion /exclusion criteria {#S0002-S2002}
-----------------------------

Studies were included if they involved qualitative or mixed methods, were published between January 2005 and March 2016, included an adolescent population in the age range 10--19 years (if the study included children, young adults or adults, it was included so long as the adolescent population was distinct in the results), were conducted in one or more countries within SSA (or included a defined population in SSA) and stated aims that included an assessment of factors influencing adolescent engagement with at least one stage of the HIV care cascade. Only articles published in English were included.

Quality appraisal {#S0002-S2003}
-----------------

The importance of appraising the quality of health research is increasingly recognized, although challenges include the lack of a standardized method or approach \[[36](#CIT0036),[37](#CIT0037)\]. The Oxford Critical Appraisal Skills Programme (CASP) criteria is one of the most widely used checklists for qualitative research, enabling an assessment to be made of a study's validity, rigour and relevance \[[38](#CIT0038)\].

Two researchers (SW, LG) reviewed all articles according to the ten-point scale proposed by CASP and scored them independently. One point was given for each checklist criterion present in the research article and zero points were given for absent criterion. Individual scores were compared and differences deliberated until an agreement was reached. Any scoring not reached in agreement was submitted to a third researcher (AW) for final review.

Thematic analysis {#S0002-S2004}
-----------------

Thematic constructs were noted according to the methods of conducting meta-ethnographic analysis suggested by Noblit and Hare \[[19](#CIT0019)\] and findings were applied to the SEM. In each article, first-order constructs were identified through study participant quotations in the text. Second-order constructs were then distinguished from these based on the researchers' perspectives, mainly presented in the discussion sections of research articles. Comparison of first and second order constructs was examined chronologically across studies that explored the same stage of HIV care. Articles that covered more than one stage of care were catalogued into each stage of the cascade sequentially, for a complete analysis of themes specific to that stage. Third order constructs were then defined to contextualize all identified themes across the entire cascade of care, noting reciprocal and highly salient constructs.

Results {#S0003}
=======

Characteristics of included studies {#S0003-S2001}
-----------------------------------

In total, 3089 publications were identified through the search. Following the review of titles and abstracts, 2974 were excluded for not meeting the inclusion criteria, most of which were quantitative studies. The remaining 115 articles were reviewed in full, following which an additional 92 were excluded (the majority for lacking results specific to adolescents). 1 additional relevant study was discovered searching article references. In total, 24 qualitative and mixed methods articles were selected for inclusion in the meta-ethnography ([Figure 2](#F0002)).Figure 2.Flow diagram showing search strategy and number of articles identified at each stage.

The eligible articles were catalogued in accordance to HIV care cascade stages (i.e. HIV diagnosis, linkage to care, engagement/retention in pre-ART care, ART initiation and adherence), and within those stages arranged chronologically by year of research. [Table 1](#T0001) presents the characteristics of included studies.Table 1.Characteristics of included qualitative and mixed methods studies\#Care stage(s)1st author, yearYear of researchLocationSettingAge range of adolescentsData collection methodAims11Rassjo, 20072004UgandaUrban slums; Kampala10--21^a^FGD and IDI: adolescents & young adults.To evaluate young people's perceptions regarding VCT and the barriers and facilitators to testing.21Izugbara, 20092004Uganda, MalawiUrban and rural14--19FGD: adolescent malesTo offer youth perspectives on VCT; specifically, how young men navigate their identities and masculinity as they relate with HIV services.31Ferrand, 20112009ZimbabweClinics; urban suburbs, Harare10--18IDI: adolescents and guardians.^b^To investigate adolescent & guardian acceptability and rate of service uptake of PITC, as well as risk perceptions of MTCT.41Francis, [2010](#CIT0041)2009South AfricaIndustrial zones; Shongweni, Durban16--19IDI: out-of-school youth.To collect out-of-school/working youth perceptions on VCT and survey knowledge about HIV using peer researchers.51Ntsepe, 20142011South AfricaUrban community venues & schools: Cape Town, Durban12-adult ^a^FGD: adolescents, young people & adults.To evaluate differences in perception, acceptability and uptake of HTC in different racial communities in South Africa.61Strauss, 20152012--2013South AfricaRural schools: Vulindlela, KwaZulu-Natal\>16 secondary school studentsFGD: in-school adolescents.To examine barriers and facilitators to HCT uptake offered to young people in school settings.75Schenk, 20142007KenyaAreas within 5 km of paediatric HIV clinics in Narobi, Eastern & Nyanza provinces\<15 ^a^IDI: Caregivers, HCW, clinic managers & MoH reps.To define demand side barriers to uptake of HIV services for perinatally infected children \<15, with an elaboration on the challenges specific to adolescents.85Mavhu, 20132009ZimbabweAfricaid community support groups -- Harare (urban)15--18FGD & IDI: ALHIV, caregivers, HCW. Life narratives: ALHIV.^b^To strengthen the evidence base for a psychosocial intervention planned by Africaid for ALHIV utilizing community spaces to host peer support groups.95Lowenthal, 20142009--2010BotswanaClinics: Gaborone (urban)10--19IDI: ALHIVTo identify the culturally specific factors necessary to adapt in order to best utilize western tools for psychosocial assessment when exploring correlates of adherence for ALHIV in SSA.105Li, 20102010South AfricaUrban clinic: Cape Town10--15FGD: ALHIVTo identify experiences, needs and illness perspectives of both behaviourally and perinatally infected ALHIV.115Denison, 20152011--2012ZambiaTwo ART clinics (1 children's, 1 general) -- Ndola (urban)15--18IDI: ALHIV and caregivers.To explore ART adherence from the perspective and experiences of older adolescents (15--18) and their caregivers.125Nyogea, 20152011--2012TanzaniaChronic disease clinic -- Ifakara (rural)13--17 Qualitative (equal component)FGD, IDI: ALHIV & caregivers.^b^To estimate adherence levels and find the determinants of ART adherence for children and adolescents.135Vreeman, 20122012KenyaAMPATH clinics: urban & rural10--18IDI: adolescents & caregivers. Cognitive interviewing: ALHIV.To improve understandability of paediatric ARV adherence measurement items used in resource limited settings through cognitive interviewing.145Mutumba, 20152012UgandaUrban clinics13--19IDI: ALHIVTo identify the psychosocial challenges and coping strategies of perinatally infected ALHIV.155Mupambireyi, 20142011--2013ZimbabweLow income, suburbs11--13FGD & IDI: adolescents & caregivers.^b^To explore peer social support experiences of young, perinatally infected adolescents.165Bernays, 20152011--2013Uganda, ZimbabweClinics: Multi-site, recruited from ARROW Trial11--13IDI: ALHIVTo examine experiences of living with HIV on ART from the perspective of young ALHIV, carers and HCWs.175Cluver, 20152013South AfricaClinics: Eastern Cape, low resource province10--19IDI: ALHIV. FGD: adolescents, caregivers & parents.^b^To examine associations between knowledge of HIV+ status (disclosure) and ART adherence.182, 5Kunapareddy, 20142007KenyaAMPATH clinics: urban & rural10--16FGD & IDI: ALHIVTo identify key factors related to medication adherence for perinatally infected ALHIV on ART culturally specific to SSA.192, 5Mattes, [2014](#CIT0050)2008--2011TanzaniaOrphanages and private homes -- Tanga9--19 ^a^IDI: ALHIV & caregivers. Observation: ALHIV. Photo elicitation: ALHIV.To compare national guidelines for HIV disclosure and treatment management with the lived realities of ALHIV.202,3Petersen, 20102010South AfricaHospital -- Durban (rural)14--16IDI: ALHIV and caregivers.To develop an understanding of psycho-social challenges and protective influences promoting socio-emotional coping; to inform mental health promotion and HIV prevention programmes.212, 5Hodgson, 20122010ZambiaClinics: 1 Kalomo province (rural); 2 Lusaka & Kitwe province (urban)10--19IDI & FGD: adolescents, parents & guardians.To explore and document the educational, psychosocial and SRH needs of ALHIV.222, 3, 4, 5Mburu, 20142010ZambiaHIV clinics: Kalomo (rural), Kitwe & Lusaka (urban)10--19IDI & FGD: adolescents, parents & caregivers.To examine the experiences of ALHIV, with emphasis on how factors fit within the construct of the social ecosystem.233, 4,5Midtbo, 20122011Botswana, TanzaniaBotswana: 1 urban hospice, 1 rural clinic. Tanzania: urban community support setting.12--20^a^IDI, FGD & observation: ALHIV & young peopleTo understand and identify pathways between disclosure, ART and psychosocial wellbeing, from perspectives of ALHIV.242, 3, 4Busza, 20142011TanzaniaUrban and rural community settings: Dar es Salaam15--19FGD: HBC providers. IDI: ALHIV, caregivers & HBC providers.To examine the experiences of ALHIV in order to identify ways to improve HBC to better meet their needs.[^1][^2]

The majority of identified studies were conducted in Southern and Eastern Africa with notable gaps in some high prevalence countries, including Mozambique, Swaziland and Lesotho ([Figure 3](#F0003)).Figure 3.Map of countries in SSA with published qualitative research on the ALHIV care cascade.

Out of the 24 studies included in our review, 6 explored issues related to cascade stage one, HIV testing, and 11 explored factors related to stage five, ART adherence. The remaining 7 studies examined multiple stages of the cascade. No qualitative studies were identified that specifically aimed to explore factors influencing ALHIV linkage to care following diagnosis (stage 2), engagement/retention in general medical care (stage 3) or initiation onto ART (stage 4).

Quality assessment {#S0003-S2002}
------------------

Eighteen out of 24 (75%) of the included studies were rated moderate to high quality, scoring 7--10 points on the CASP scale; and none of the studies scored below six points. The CASP criteria least achieved (absent in 13 out of 24 articles (54%)) was a failure to elaborate on the relationship between researchers and study participants (CASP criteria 6).

Themes influencing the engagement of ALHIV in care and treatment services {#S0003-S2003}
-------------------------------------------------------------------------

Twelve third-order themes were identified, many of which acted across multiple levels of the SEM ([Table 2](#T0002)). Salient themes are presented by order of importance, determined by number of studies they were reported in and instances of overlap within the models.Table 2.Themes: First-, second- and third-order constructs and their positioning across the levels of the SEM3rd order constructs2nd order constructs + source papers1st order constructs + source papersSEM LEVELSCare stagesStigma *n* = 23Anticipated stigma surrounding being seen utilizing HIV services (1,2,3,4,5,6,17,20)*"Let me say there is this particular lady who works at the clinic who is also a neighbour, this lady might see that particular person going to do a HIV test and tell the family..." -- Strauss, p 7.*  Anticipation of knowing people at the clinic (4,6)  Anticipated isolation from peer group (1,2,4,5)*"...if you are going for an HIV test its going to be stigmatized that you are sexually active and a lot of us youngsters do not want people to think that and know that." --* Ntsepe, p 144.  Anticipated assumptions regarding sexual activity (2,3,5,21)  Anticipation of unwanted disclosure after being seen using HIV services (20,24)*"My child was pinned a red label on his shirt by his teacher after he knew the HIV and treatment status of the child."* -- Nyogea, p 7.I,F,C,SAllAnticipated stigma from family member (2,3,5,12,14,18)  Enacted stigma from teachers towards ALHIV (7,12,14,22,23)  Anticipation of disclosure at school by carrying medication (11,14)  Desire to appear "normal", avoid enacted stigma associate with symptoms (14,16)*"Nurses in Soweto do not treat you like human beings. They stigmatize you and by the time you leave there you have a different mindset"* -- Forrest, p S58.  Enacted stigma from judgemental or reprimanding HCWs (13,15,18,19,21)  Anticipated stigma prioritizes secrecy routines over medication adherence (7,8,9,10,11,12,13,14,16,18,23)   Self-efficacy surrounding adaptive mechanisms *n* = 19Fear of being incapable of making lifestyle changes (1,2,5,6)*"It isn't just to go and test, you feel everything, you never know -- because they say a piece of paper can upset your life." --* Ntsepe, p 143.I1, 3, 5Fears over psychological reactions: depression, anxiety, suicide, "thinking too much" (1,2,3,5,6,19)*"...for elder children some will show signs of fatigue with medication. You can hear a child asking why he must take another dose and he is not feeling sick."* -- Schenk p 24.  Health awareness /knowing ones status (1,3,4,5,6,11,17,18,22,23)\
Frustration surrounding side effects (9,11,12,14,16,19,21)\
Drug fatigue (7,12,14,16,18)\
Forgetting (8,12,18)\
Frustration surrounding lack of independence /reactance (9,17,18)\
Morning dose problems (oversleeping, late) (12,18)\
Travelling /not being home /school trips interfere with medication routine (8,9,11,18)\
Pill burden, complicated medication prep (14,18)\
Using alarms & reminder devices (11,14,18)*"Especially if I am really busy with school or anything, I set an alarm so I can remember coz I easily forget to take my drugs."* -- Denison p 4.   Concerns over losing family support: financial or neglect/abuse (1,2,3,5)*"After my father's death we had a family meeting, where my family refused to let me stay with them."* -- Midtbo, p 267.   Guardian fails to give consent (3)    HIV+ family members as role models (3,10,20)*"I had some fear inside: how will my parents accept it... If only I was above 18 years I could stand for myself but now I am dependent on my parents*." Ferrand, p 2327.   Peer or guardian encouragement to test (3)    Empathy from family members (21)   Family support *n* = 17Full, timely disclosure by family (8,14,17,18,19,22,23) F1, 2, 4, 5 Family assisted medication reminders (7,8,9,10,11,14,18,19,23)    Neglect /orphanhood (8,14,19)\
Punishment for adherence slips leads to dishonesty (16,18)\
Skills training, education and support for caregivers (11,20)*"I: You said if your mother was still around things would not be happening the way they are now. Is there anything that you think would be happening differently..? R: Yes. I: Like what? R: Like love." --* Peterson, p 972.   HIV counselling offered with no pressure to test (1,3,4,6)*"Here (at the clinic) they may be talking about pills, but at the support group children will be talking about their experiences..." --* Mupambireyi p 109.   Pre- and post-test counselling available (3,6)    Community HIV & SRH educational available (2,19)   Broader social support *n* = 17ALHIV outreach services /peer support (19, 23) C1, 2, 3, 5 School support /selective disclosure to "safe" teacher (6,10,14,18,23)    ALHIV community support groups (8,15,19,21,24)\
Sensitization of teachers & school staff (7,22)\
Treatment buddies (15,20)\
Testing at home /home based care (6,24)*"When I was still in school I used to face cases of discrimination from other students, which lead me to tell my teacher to help me." --* Midtbo, p 266.   Youth targeted services & hours (4,7,9,17,18,21,22,23)*"At the moment, adolescents are being sidelined. Adults are able to talk for themselves and children are also represented but no one represents the adolescents"* Mburu, p 15S1, 2, 3, 5Adolescent specific health services *n* = 12Nurses, counselorscounsellors with similar characteristics to patient (age range, gender) (2,17)\
HCW trained to work with youth /ALHIV (18,20,24)\
HC facilatiesfacilities that offer HIV and SRH education (17,23)\
Clinic co-ordinated disclosure process with families (17,19)\
Full disclosure by HCWs of HIV status and what ARVs are for (15,23)*"... they are at such a difficult stage in their lives, to add to that 'Now you've got HIV', and all the implications of that, it slays them."* -- Cluver, p S62.   Uninformed about services cost & location (1,2,3,4,6)*"I would go to a clinic far from home. There are so many people attending the local clinic who know me. I wouldn't want them to know." --* Francis, p 338.   Uninformed /fearful of what testing proceedureprocedure entails (1,2,6)\
No privacy /confidentiality concerns (4)*"People come and do things so fast because they want to go back fast -- they talk fast, write drugs, and then say 'Next'."* -- Mburu, p 15.  Adequacy of health systems *n* = 12Appointments take too long (waits /queues) (1,3,6,21)\
ReferedReferred/linked to care following diagnosis (21,24)\
HCWs sensitized to work with HIV+ people (21,24)\
Long distance to clinic (2,8)\
Support groups /mental health services offered at the clinic (11,12,14,19)\
Understaffed clinics (21)\
\
\
\
*"At the clinic we try to be as friendly as we can with adolescents... but sometimes we have a lot of pressure, especially with adult clients, so you lose your temper." --* Hodgson, p 1208.S1, 2, 3, 5 Long term symptomatic /history of severe illness prompts testing (3)*"You try and remind them \[the child\] how they were ... Then they will say 'I was not going to school', 'I was not able to do this and that' and you will ask them if they want to go back to the same situation." --* Bernays, p 277.  Past illness narratives *n* = 10HCW using reminders of past illness to motivate ART adherence (17)\
Individual's ART adherence motivated by fear of becoming sick again (9,10,11,12,16,19,23)\
Motivation to adhere to ART falters after symptom recovery (9,12,16,18)*"I took the ART for some months and I felt fine, so I stopped taking them because I felt I was no longer ill." --* Midtbo, p 265.I, S1, 5 Unable to meet indirect costs of care (travel to clinic, medication for opportunistic infections) (2,8,10,15,17,19)*"I wanted to go on my own before I became seriously ill but I had no money for transport and to pay at the clinic."* -- Ferrand, p 2328.  Financial instability *n* = 10Incentives provided; food, soap, travel reimbursement, skills training (20)*"Please government, give people \[who\] have HIV food. And more money."* -- Li, p 755.F,S2, 3, 4, 5 Mandatory ART counselling not offered for free (22)\
Household food insecurity limits ART adherence (8,13,16,19)*"I have a prescription to go and buy drugs \[for OI treatment\] for my child but I don't have the money. This child needs medication immediately."* -- Schenk, p 21.   Non-full disclosure by guardians about what medication is for (11,12,13,15,23)*"Then they say I have malaria... so they will give me medicine... but I cannot start taking the medicine if I do not know where I got the malaria from."* -- Mupambireyi, p 109.  Social coping mechanisms *n* = 9Assigning reasons for taking medication to alternate illness to prevent unintended disclosure (7,11,14,19,22)*"... my friends don't know that I had the virus \[so I said\] I felt some malaria."* -- Denison, p 2.I,F5 Family goals /women planning pregnancy (1,3,4)\
Goals (family, career or education) facilitates linkage & retention in HIV care (10,19,23)*"As a mother, I need to be healthy for the sake of my child. I want to set an example by making good decisions."* -- Francis, p 336.  Future orientation *n* = 9Perception of having "no future" following diagnosis as a barrier to testing and care enrollmentenrolment (2,4,10,20)\
Family, education or life goals as ART adherence motivators (10,12)*"I am scared because I want to finish school and you know, get a job and have a boyfriend, but I don't know how to do that as a person with HIV." --* Li, p 755.I1, 2, 5Media influence *n* = 7Media influenced adolescents HIV knowledge /"Know Your Status" campaign (1,2,3,4,5,6)*"I would go for VCT because it's importland to know my status. It will help me stay protected and also protect others."* -- Francis, p 336.C1, 2 Media campaigns to reduce HIV service stigma (2,22)    Traditional medicine used to avoid costs of care (7)   Reliance on traditional medicine *n* = 5Caregiver decision to treat with TM (12,13)\
TM practicionerspractitioners claiming to heal HIV (7,11,18)\
Medication mythology /mistrust of ART (12,18)*"I used those herbs and I have even drunk urine because there is someone who came and lied to us that drinking urine can heal HIV." --* Kunapareddy, p 391.F,C1, 2, 5[^3][^4]

Stigma {#S0003-S2004}
------

Debilitating experiences with stigma were described in every study, manifesting as internalized, anticipated and externalized barriers to progression through all stages of the cascade. Anticipated stigma (fears surrounding social exclusion) was common at the individual level, negatively influencing motivations to obtain an HIV diagnosis \[[39](#CIT0039)--[46](#CIT0046)\] and to follow up on test results \[[44](#CIT0044),[45](#CIT0045)\]. This was reinforced by experiences with external stigma at other levels including: family neglect or ostracism from peers \[[39](#CIT0039),[40](#CIT0040),[43](#CIT0043),[47](#CIT0047)--[50](#CIT0050)\], community gossip \[[41](#CIT0041)--[43](#CIT0043),[46](#CIT0046)\], discrimination in school \[[49](#CIT0049),[51](#CIT0051)--[54](#CIT0054)\] or lack of empathy from health care workers (HCW) \[[45](#CIT0045),[50](#CIT0050),[55](#CIT0055)--[57](#CIT0057)\]. Such social conditions reinforced barriers to HIV care linkage, retention in HIV services and adherence; with ALHIV often choosing to prioritize secrecy around their disease status over unintended disclosure \[[48](#CIT0048),[51](#CIT0051)--[55](#CIT0055),[57](#CIT0057)--[60](#CIT0060)\]. This choice frequently accounted for missed ART doses when social conditions were unfavourable, such as having minimal privacy in the home \[[49](#CIT0049),[51](#CIT0051),[53](#CIT0053),[57](#CIT0057)\] or at school \[[49](#CIT0049),[52](#CIT0052)\].

Self-efficacy to adapt to a life with HIV {#S0003-S2005}
-----------------------------------------

Adolescents understood that the event of receiving an HIV positive diagnosis would require them to make lifestyle changes that, in many instances, they lacked confidence to adopt. Fear surrounding the ability to manage the consequences of a positive diagnosis frequently created a barrier to testing \[[39](#CIT0039),[40](#CIT0040),[42](#CIT0042),[43](#CIT0043),[47](#CIT0047)\]. Such diminished self-efficacy similarly affected ALHIVs' capacity to maintain new health behaviours over time, such as the ART adherence necessary to achieve viral suppression, due to frustration surrounding the ongoing nature of treatment or side effects \[[48](#CIT0048)--[53](#CIT0053),[57](#CIT0057),[58](#CIT0058),[60](#CIT0060),[61](#CIT0061)\]. Lack of self-efficacy was often associated with an absence of empathetic support to adolescents offered within HIV services regarding how to integrate these required new behaviours into their lifestyles \[[45](#CIT0045),[49](#CIT0049)--[53](#CIT0053),[57](#CIT0057),[58](#CIT0058),[60](#CIT0060)\]. Self-efficacy was restored through acts or interventions that operated at other levels of the SEM including support from family members, participation in community support groups or support from treatment buddies \[[48](#CIT0048)--[52](#CIT0052),[54](#CIT0054),[57](#CIT0057)--[59](#CIT0059)\].

Family support {#S0003-S2006}
--------------

The presence or absence of family support strongly influenced adolescents' testing, linkage to care, and adherence to ART. Definitions of "family" were broad, and could include biological parents, distant relatives, close friends and /or other caregivers. "Support" was defined as empathy, encouragement or care provided during sickness \[[52](#CIT0052),[57](#CIT0057)\], having an HIV-positive role model \[[47](#CIT0047),[59](#CIT0059)\] and assistance with medication reminders \[[48](#CIT0048)--[52](#CIT0052),[54](#CIT0054),[57](#CIT0057)--[59](#CIT0059)\]. Lack of family support included non-full disclosure to ALHIV of their status \[[46](#CIT0046),[48](#CIT0048)--[50](#CIT0050),[54](#CIT0054),[57](#CIT0057),[61](#CIT0061)\], neglect or abuse \[[48](#CIT0048)--[50](#CIT0050)\] and failure to provide consent for services \[[47](#CIT0047)\], all of which negatively influenced movement through the care cascade.

Broader social support {#S0003-S2007}
----------------------

The inclusion of social services in communities was cited as facilitating engagement at all stages of the HIV care cascade. ALHIV support groups \[[44](#CIT0044),[45](#CIT0045),[48](#CIT0048),[54](#CIT0054),[56](#CIT0056)\], home-based care \[[43](#CIT0043),[62](#CIT0062)\] and HIV /sexual and reproductive health education through school or outreach programmes \[[40](#CIT0040),[45](#CIT0045),[50](#CIT0050),[54](#CIT0054)\] were all detailed as beneficial resources. The presence or lack of support within schools in particular was influential in terms of ART adherence, experiences with discrimination from other students or teachers negatively influenced the ability of ALHIV to carry medication and manage a dosing schedule at school \[[49](#CIT0049),[51](#CIT0051),[53](#CIT0053),[54](#CIT0054)\], and crowded environments with no privacy, particularly in boarding schools, exacerbated fears surrounding unintended disclosure \[[49](#CIT0049),[52](#CIT0052),[57](#CIT0057),[58](#CIT0058)\]. However, when selective disclosure to a "safe" teacher or school nurse was obtained, it frequently facilitated good adherence to ART \[[49](#CIT0049),[51](#CIT0051),[54](#CIT0054),[59](#CIT0059)\].

Adolescent-specific health services {#S0003-S2008}
-----------------------------------

ALHIV often faced difficulties in transitioning between paediatric and adult models of care; several studies reported that health services which catered specifically to adolescents' needs positively influenced their progression through the cascade. Services which accommodated "youth-friendly" hours that didn't interfere with school or work were often cited as facilitating access to HIV testing, pre-ART care and ART \[[41](#CIT0041),[45](#CIT0045),[46](#CIT0046),[51](#CIT0051),[57](#CIT0057),[58](#CIT0058),[61](#CIT0061)\], as were HCWs who had undergone specific training to work with adolescents \[[44](#CIT0044)--[46](#CIT0046),[57](#CIT0057),[62](#CIT0062)\]. In addition, adolescents expressed a preference for HIV counsellors who shared similar characteristics to themselves (age range or gender) to avoid feeling that counselling messages were condescending \[[40](#CIT0040),[46](#CIT0046)\]. Sexual and reproductive health education incorporated into health services \[[46](#CIT0046)\] and HCW participation in the disclosure processes \[[46](#CIT0046),[50](#CIT0050),[54](#CIT0054),[56](#CIT0056)\] were found to positively influence both ALHIV retention in care and adherence.

Adequacy of health systems {#S0003-S2009}
--------------------------

Adolescents' linkage to and retention in care were affected by the ability of the health system to provide efficient, confidential and comfortable services. This included the presence or absence of outreach efforts to inform ALHIV about service availability \[[39](#CIT0039)--[41](#CIT0041),[43](#CIT0043),[47](#CIT0047)\], pre- and post-test counselling options \[[39](#CIT0039),[41](#CIT0041),[43](#CIT0043),[47](#CIT0047)\] and employment of sufficient numbers of HCW of various cadre \[[39](#CIT0039),[43](#CIT0043),[45](#CIT0045),[47](#CIT0047)\]. The infrastructural capacity to avail space within health facilities to ensure privacy \[[45](#CIT0045),[62](#CIT0062)\] and the total time required for appointments based on queues and travel to and from the clinic further compounded barriers to both HIV diagnosis and retention in care \[[39](#CIT0039),[40](#CIT0040),[43](#CIT0043),[45](#CIT0045),[47](#CIT0047),[48](#CIT0048)\].

Past illness narratives {#S0003-S2010}
-----------------------

Experiences with physical deterioration and severe illness could often facilitate engagement in HIV care, specifically in regard to receiving an HIV diagnosis \[[47](#CIT0047)\] and adhering to treatment \[[50](#CIT0050),[52](#CIT0052)--[54](#CIT0054),[58](#CIT0058)--[60](#CIT0060)\]. Within families and at health facilities, these past illness narratives were used as reminders by caregivers and HCWs to facilitate ALHIV's adherence to ART \[[46](#CIT0046),[60](#CIT0060)\]. Conversely, experiencing improvements in symptoms could also hinder adolescents' ART adherence, particularly if their HIV status had not been fully disclosed to them, or they had limited knowledge about their illness and its treatment requirements: several studies identified faltering adherence among ALHIV who had regained physical strength and a "normal" appearance \[[51](#CIT0051),[53](#CIT0053),[57](#CIT0057),[58](#CIT0058),[60](#CIT0060)\].

Financial instability {#S0003-S2011}
---------------------

The direct and indirect costs of care and treatment acted as a barrier to HIV care engagement, demonstrated at the family and structural level of the SEM. The cost of transportation to reach appointments \[[40](#CIT0040),[46](#CIT0046),[48](#CIT0048),[55](#CIT0055),[56](#CIT0056),[59](#CIT0059)\] or additional food required to satisfy the nutritional needs of adolescents on ART \[[48](#CIT0048),[50](#CIT0050),[55](#CIT0055),[60](#CIT0060)\] negatively influenced family willingness or ability to support ALHIV. At the structural level, the absence of available financial assistance to cover the costs of medications for opportunistic infections or ART counselling exacerbated the situation \[[50](#CIT0050),[60](#CIT0060),[61](#CIT0061)\]. Conversely, one study found that the inclusion of economic incentives including food, household provisions or travel reimbursement encouraged linkage to care among ALHIV \[[44](#CIT0044)\].

Social coping mechanisms {#S0003-S2012}
------------------------

In multiple studies, adolescents described a variety of coping mechanisms to navigate social situations that threatened unwanted disclosure. Such strategies included ALHIV claiming that their drugs, AIDS symptoms or prolonged school absences were the result of an alternate condition, such as heart problems or malaria \[[49](#CIT0049),[50](#CIT0050),[52](#CIT0052)--[56](#CIT0056),[61](#CIT0061)\]. These strategies were also used by caregivers and HCWs to avoid disclosure to younger ALHIV of their true condition at the family and structural SEM levels \[[51](#CIT0051),[54](#CIT0054),[57](#CIT0057),[58](#CIT0058)\]. Such tactics were utilized to facilitate short-term ART adherence, despite their apparently limited effectiveness to help ALHIV achieve sustained adherence to treatment.

Future orientation {#S0003-S2013}
------------------

Future aspirations, and the ability to identify personal goals including marriage, pregnancy or further education were cited in several studies as factors that motivated ALHIV to obtain an HIV diagnosis \[[39](#CIT0039),[41](#CIT0041),[47](#CIT0047)\], to link to HIV care \[[58](#CIT0058)\] and to adherence to their antiretroviral therapy \[[53](#CIT0053),[59](#CIT0059)\]. However, adolescents' fear of having diminished options in the future following a positive HIV diagnosis acted as a barrier to diagnosis and ART adherence \[[40](#CIT0040),[41](#CIT0041),[44](#CIT0044),[59](#CIT0059)\]

Media influence {#S0003-S2014}
---------------

Mass media campaigns were identified as effective in promoting knowledge surrounding HIV risk factors and diagnosis. The HIV testing campaign slogan ALHIV repeatedly referenced was the "Know Your Status" (KYS) campaign, that originated in Lesotho \[[63](#CIT0063)\]. The "KYS" slogan and associated statements regarding the moral imperative of testing were recited by adolescents in multiple countries during interviews \[[39](#CIT0039),[41](#CIT0041)--[43](#CIT0043),[47](#CIT0047)\]. However, researchers noted that despite this familiarity with the KYS campaign, rates of testing often remained low \[[40](#CIT0040),[41](#CIT0041)\]. Media campaigns were also detailed as a means of counteracting community stigma towards ALHIV that undermined HIV service enrolment \[[40](#CIT0040),[61](#CIT0061)\].

Reliance on traditional medicine {#S0003-S2015}
--------------------------------

The use of traditional medicine was identified in the SEM at the family and community levels as a barrier to linkage to HIV care and to ART adherence. Reliance on traditional medicine for health care delayed the initiation of ART \[[52](#CIT0052),[57](#CIT0057),[60](#CIT0060)\], and was favoured at times by caregivers \[[53](#CIT0053),[55](#CIT0055)\] with reduced costs cited as justification for their use by economically strained families \[[60](#CIT0060)\]. Lack of community HIV and ART education also contributed to the perpetuation of local disease mythologies associated with the use of traditional medicine to treat HIV \[[57](#CIT0057),[60](#CIT0060)\].

Discussion {#S0004}
==========

Our meta-ethnographic approach to the analysis of qualitative literature published across varying contexts in SSA revealed striking thematic similarities across different countries and over time. Stigma, family support, self-efficacy and social support were common themes resonating across multiple settings in SSA and across the 10-year period of inquiry. The degree of consistency in these findings across diverse settings suggests that similar interventions to improve the uptake of HIV care among ALHIV may be relevant in many SSA countries.

Out of 24 selected articles, only seven investigated multiple stages of the HIV care cascade. Most of the studies focused on discreet aspects of HIV care and treatment, in particular testing or adherence, leaving stages such as linkage to care and initiation onto treatment under-represented. In order to better understand the impacts of efforts being made to achieve the UNAIDS 90-90-90 targets \[[64](#CIT0064)\], further investigation of the full spectrum of ALHIV experiences with HIV care is needed.

During the time-period evaluated, the most significant efforts to promote HIV engagement have primarily acted at the structural level: for example, free ART provision, expansion of counselling and testing services and formation of support groups in many clinics. However, it was the threat of social isolation as a result of attitudes towards HIV that emerged as the most influential factor hindering ALHIV progression through all stages of the care cascade. Detrimental experiences with stigma were the most salient theme across the entire time-span, suggesting that structural-level interventions have had limited impact on individual experiences of living with HIV over the last 10 years.

Given that structural interventions alone are unlikely to act at multiple levels of the SEM, the potential of youth-specific services to improve rates of care retention in SSA (a facilitator to HIV care engagement detailed in numerous articles) is ultimately reliant on the presence of mutually improved conditions at the other SEM levels \[[65](#CIT0065)\]. Their ability to facilitate the movement of ALHIV through the stages of the care cascade is contingent upon caregiver support, community perceptions of services, and experiences of stigma associated with their use. Further, training new or existing HCWs to work with adolescents, expanding services to youth-friendly hours and improving upon the efficiency of appointments all require a sustained and substantial economic commitment \[[66](#CIT0066)\] which is in turn dependent on international funding priorities and domestic health policies \[[67](#CIT0067)--[70](#CIT0070)\].

We noted that stigma was commonly anticipated by ALHIV, often manifest through fear of unwanted disclosure of their positive status after being seen using HIV services or taking medication. These individual level fears pervaded into other SEM levels, where they threatened to deteriorate relationships with loved ones or result in ostracism by the community. The power of such anticipated stigma to negatively affect adolescent care engagement in SSA cannot be overstated, particularly as it compounds the hardships that many ALHIV have already gone through following early parental loss and learning their own positive HIV status. This appears distinct from the dominant manifestations of stigma amongst adults living with HIV in SSA \[[71](#CIT0071),[72](#CIT0072)\]. The stigma experienced by many adults living with HIV is inextricably linked to blame or promiscuity \[[51](#CIT0051),[73](#CIT0073)\]. Witnessing such enacted stigma demonstrated towards adults may not only reinforce anticipated stigma in ALHIV at the individual level, but also presents a barrier to their care at other levels of the SEM where they require the support of adults. For example, guardian experiences' with enacted stigma may result in failure to provide ALHIV with the consent and accompaniment required to access HIV care in some areas, out of their own unwillingness to be seen utilizing HIV services \[[51](#CIT0051),[74](#CIT0074),[75](#CIT0075)\]. Our findings suggest that interventions to address stigma need to account for the inherent differences between ALHIV and adults living with HIV. Care should be taken to not assume that the same forces driving stigma amongst an adult population resonate amongst adolescents.

In the absence of coordinated support to address treatment challenges among ALHIV, motivational techniques were often applied by caregivers or HCWs, such as the use of past illness narratives to facilitate ART adherence based on ALHIVs' desires to maintain "normalcy" \[[49](#CIT0049),[53](#CIT0053),[57](#CIT0057),[58](#CIT0058),[60](#CIT0060)\]. Our meta-ethnography highlights that HCW used the motivation of "staying well" to encourage adherence, insinuating a comparison to a past period of ill health. Further, both ALHIV and their caregivers reported inventing an alternate illness to attribute medication use to, either to avoid disclosure from caregiver to ALHIV or from ALHIV to the wider community of extended family, peers and teachers. The use of past or alternative illness narratives represent makeshift approaches to adherence and disclosure that have been utilized in the absence of broader social support to help ALHIV manage care dilemmas attached to stigma. Recent changes in guidance for ART eligibility to include all who test HIV positive regardless of their immune status or WHO staging \[[69](#CIT0069),[76](#CIT0076)\] should reduce the occurrence of "past illnesses" and could therefore change how ALHIV engage with HIV care. Social approaches to managing engagement in HIV care and adherence should encourage early and ongoing disclosure assisted by HCWs, rather than being left to the responsibility of families alone \[[30](#CIT0030),[77](#CIT0077)--[79](#CIT0079)\]. This coordinated disclosure will need to place greater emphasis on sustainable facilitators to self-efficacy, such as future orientation, to avoid use of short-term tactics that fail to recognize the capacity of ALHIV to understand and manage their illness.

The self-efficacy of ALHIV is recognized as a key facilitator to diagnosis, retention in care and adherence to ART. However, its effect is reliant on social conditions such as family environment, presence or absence of peer support and the attitudes of HCWs working with youth. Inclusion of supportive social conditions at different levels of the SEM, such as community support groups, family counselling and HIV /sexual and reproductive health education, has the potential to bolster self-efficacy and motivate ALHIV through the stages of care \[[80](#CIT0080)--[83](#CIT0083)\]. In the absence of supportive conditions, ALHIV self-efficacy may fail to develop or result in rebellion against their care management \[[84](#CIT0084)\] as they gain further independence with age, yet maintain a sense of social isolation and frustration surrounding treatment adaptation.

We concur with others that have taken a critical stance on the utility of a linear model of the HIV care cascade with a proposed end-point of viral suppression \[[85](#CIT0085)\]. Our systematic review of evidence suggests that such a model is not sufficient to generalize the ongoing and evolving process of managing a lifelong condition for ALHIV. In [Figure 4](#F0004), we illustrate how the reality is a succession of ebbs and flows as ALHIV attempt to "scale a waterfall" to achieve viral suppression. Ethnographic and qualitative descriptions portray movement which requires upward momentum to move through these stages, with ALHIV using facilitators as footholds to manoeuvre against a downward cascade of barriers that persistently threaten to undermine their intentions to engage in HIV care.Figure 4."Scaling a waterfall": upward momentum among ALHIV through the HIV care cascade stages.

Our study is affected by various limitations inherent to qualitative studies and the meta-ethnography design. Adolescents may be prone to social desirability bias in their responses, particularly when discussing behaviours such as ART adherence or clinic attendance. In addition, most of the studies in our analysis adopted a cross-sectional rather than a longitudinal design, which may have been better suited to identify issues related to transition between paediatric and adult models of HIV care. Our search was limited to publications in English which may partially explain the geographic gaps in the research studies that we identified; however, these gaps may also be influenced by differences in research funding across countries. Although our search criteria were broad, some relevant studies may not have been captured by our choice of terms; yet this risk should be minimized by our strategy of searching through the reference lists of relevant articles. Furthermore, due to limited available research exploring gendered differences in adolescent HIV care, our ability to unpick gender-specific factors influencing cascade progression was limited. Additional qualitative research should be undertaken to explore the risk perceptions, knowledge of HIV transmission, sources of SRH education and experiences of adolescent females with HIV services, not only because they are at higher risk of acquiring HIV \[[6](#CIT0006),[64](#CIT0064),[86](#CIT0086),[87](#CIT0087)\], but also because their experiences with stigma may profoundly reinforce barriers to testing or ART for PMTCT \[[80](#CIT0080),[88](#CIT0088),[89](#CIT0089)\].

To our knowledge, this is the first meta-ethnography of research on factors influencing engagement in HIV care among adolescents in SSA that examines treatment progression holistically, by synthesizing studies focused on different aspects of the care cascade. Our use of a socio-ecological lens provides a comprehensive view of the issues influencing HIV care engagement, and enables us to analyse the interplay between individual, family, community and structural factors. The findings generated through this review are timely given the current focus on adolescent health within global health initiatives and also since the adolescent HIV epidemic in the region has peaked, and readiness to test, commence treatment and adhere successfully to ART is essential in reducing transmission rates and preventing drug resistance \[[77](#CIT0077)\]. Significant efforts are still required to ensure that this important age group do not fall further behind in the global effort to eradicate AIDS by 2030 \[[90](#CIT0090)\].

Conclusions {#S0005}
===========

For ALHIV in SSA, individual-level issues are the most influential in preventing engagement across all stages of the HIV care cascade, although family, community and structural issues also play an important role. Despite scale-up of services and increased availability of ART in SSA over the past decade, stigma remains the most pervasive barrier to HIV care engagement, present at each level of the SEM, and hindering progression across all stages of the care cascade. Psychosocial interventions among adolescents and their families should be prioritized to improve adolescents' engagement in HIV care, enhance their wellbeing and ultimately reduce their risk of ill-health and mortality.
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[^1]: ^a^ Adolescent population distinct in results; ^b^ Study was mixed methods

[^2]: Care cascade stages: **1** -- testing; **2** -- care initiation; **3** -- in care, awaiting ART; **4** -- ART initiation; **5** -- on ART, working towards/maintaining viral suppression

[^3]: SEM levels: I -- Individual; F -- Family /Peer; C -- Community; S -- Structural.

[^4]: Cascade stages: 1 -- diagnosis; 2 -- linkage to care; 3 -- engagement /retention in care; 4 -- ART initiation and adherence; 5 -- viral suppression.
